Lipid-nanoparticle-enabled nucleic acid therapeutics for liver disorders
Inherited genetic disorders of the liver pose a significant public health burden. Liver transplantation is often limited by the availability of donor livers and the exorbitant costs of immunosuppressive therapy. To overcome these limitations, nucleic acid therapy provides a hopeful alternative that...
Saved in:
Main Authors: | Porkizhi Arjunan (Author), Durga Kathirvelu (Author), Gokulnath Mahalingam (Author), Ashish Kumar Goel (Author), Uday George Zacharaiah (Author), Alok Srivastava (Author), Srujan Marepally (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lipid Nanoparticle-Mediated Liver-Specific Gene Therapy for Hemophilia B
by: Brijesh Lohchania, et al.
Published: (2024) -
Optimization of SARS-CoV-2 Pseudovirion Production in Lentivirus Backbone With a Novel Liposomal System
by: Gokulnath Mahalingam, et al.
Published: (2022) -
Cytosolic delivery of nucleic acids: The case of ionizable lipid nanoparticles
by: Michele Schlich, et al.
Published: (2021) -
Lipid Nanoparticle-Mediated Lymphatic Delivery of Immunostimulatory Nucleic Acids
by: Dongyoon Kim, et al.
Published: (2021) -
The Future of Tissue-Targeted Lipid Nanoparticle-Mediated Nucleic Acid Delivery
by: Ruvanthi N. Kularatne, et al.
Published: (2022)